Source: Hematology, Transfusion and Cell Therapy. Unidade: HU
Subjects: POLIMORFISMO, VARIAÇÃO GENÉTICA, DOENÇAS DA MEDULA ÓSSEA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NORONHA, Thiago Rodrigo de e MITNE-NETO, Miguel e CHAUFFAILLE, Maria de Lourdes. Additional information offered by single nucleotide polymorphism array advantages in two myelodysplastic syndromes with excess blasts cases and future perspectives. Hematology, Transfusion and Cell Therapy, v. 41, n. ju 2019, p. 181-184, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.htct.2018.06.007. Acesso em: 19 abr. 2024.APA
Noronha, T. R. de, Mitne-Neto, M., & Chauffaille, M. de L. (2019). Additional information offered by single nucleotide polymorphism array advantages in two myelodysplastic syndromes with excess blasts cases and future perspectives. Hematology, Transfusion and Cell Therapy, 41( ju 2019), 181-184. doi:10.1016/j.htct.2018.06.007NLM
Noronha TR de, Mitne-Neto M, Chauffaille M de L. Additional information offered by single nucleotide polymorphism array advantages in two myelodysplastic syndromes with excess blasts cases and future perspectives [Internet]. Hematology, Transfusion and Cell Therapy. 2019 ; 41( ju 2019): 181-184.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1016/j.htct.2018.06.007Vancouver
Noronha TR de, Mitne-Neto M, Chauffaille M de L. Additional information offered by single nucleotide polymorphism array advantages in two myelodysplastic syndromes with excess blasts cases and future perspectives [Internet]. Hematology, Transfusion and Cell Therapy. 2019 ; 41( ju 2019): 181-184.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1016/j.htct.2018.06.007
